Speakers - Life Science 2.0
Stockholm Life Science Conference 2022 - Life Science 2.0
Monday, 28 November 2022
The conference addresses the need to reframe Life Science in the wake of COVID-19 and safeguard life: long-term and globally. Please, visit the conference site for more information.
Leif Johansson, Chairman of AstraZeneca
Mr Johansson is since 2012 chairman of AstraZeneca. He also holds board positions at Autoliv, Inc and Ecolean AB. He is a member of the European Round Table of Industrialists (Chairman 2009-2014), a member of the Royal Swedish Academy of Engineering Sciences (Chairman 2012-2017). He is also a member of the Council of Advisors, Boao Forum for Asia and a delegate to the China Development Forum. He was President and CEO of the Volvo Group from 1997 to 2011 and Chairman of Ericsson from 2011 until 2017. Mr Johansson holds an MSc in engineering from Chalmers University of Technology, Gothenburg.
Uğur Şahin, Co-Founder and CEO of BioNTech
Professor Uğur Şahin is a physician, immunologist, and leader in the development of novel approaches to fight cancer and infectious diseases. Ugur Sahin is co-inventor of more than 500 filed patents applications and patents. Şahin is one of the world’s foremost experts on messenger ribonucleic acid (mRNA) medicines. Şahin initiated and oversees “Project Lightspeed,” the historic development of the first mRNA vaccine for COVID-19, moving from lab and clinical testing to conditional approval within an unprecedented 11-month period. Ugur Sahin is co-inventor of more than 500 filed patents applications and patents.
Agnes Binagwaho, Vice Chancellor and co-founder of the University of Global Health Equity
Professor Binagwaho is the Vice Chancellor and co-founder of the University of Global Health Equity (UGHE), Rwanda, which focuses on changing how health care is delivered around the world by training global health professionals who strive to deliver more equitable, quality health services for all. Previously, she served the Rwandan health sector (1996-2016), first as the Executive Secretary of Rwanda’s National AIDS Control Commission, then as Permanent Secretary of the Ministry of Health, and lastly as Minister of Health for five years. She is professor of pediatrics and has published over 240 peer-reviewed articles and was named among the 100 Most Influential African Women for 2020 and 2021.
Mikael Dolsten, Chief Scientific Officer and President of Worldwide Research, Development and Medical at Pfizer
Mikael leads Worldwide Research, Development and Medical at Pfizer, and is responsible for the development of all compounds through proof of concept, with pharmaceutical sciences, safety, and medical support for the pipeline and all marketed medicines and vaccines. Mikael earned his PhD in tumor immunology and MD from the University of Lund, where he was Adjunct Professor in Tumor Immunology. He advised the Obama Administration, as well as then Vice President Biden’s Cancer Moonshot Initiative. Mikael is a named inventor on several patents and has published approximately 150 articles in international journals.
Nina is Partner and Co-Head at Trill Impact Ventures. Previously, she held positions including Head of Life Science at Industrifonden; Vice President, Strategy and Ventures at Gambro; and Management Consultant at Boston Consulting Group in Stockholm and New York. Nina holds a M.Sc. in Biomedicine and a Ph.D. in Molecular Neurobiology, both from Karolinska Institutet, including research work done at Columbia University and Hôpital de la Salpêtrière.
She currently serves on the boards of Cinclus Pharma and Stockholms Sjukhem. Recognition for her work includes the selection as a Young Global Leader by the World Economic Forum.
- Karl-Petter Thorwaldsson, Swedish Minister for Business, Industry, and Innovation
- Jenni Nordborg, Head of the Office for Life Sciences, Swedish Government Offices
- Olli Kallioniemi, Director SciLifeLab
- Helena Strigård, CEO, Director-General Sweden Bio
- Anders Blanck, Managing Director LIF
- Ketil F. Widerberg, General Manager of Oslo Cancer Cluster and Board Member of KI Holding AB
- Juan Pablo Uribe, Global Director Health, Nutrition & Population and the Global Financing, World Bank
- Jerome Kim, Director General International Vaccine Institute, IVI
- Michael Makanga, Exec. Director of European & Developing Countries Clinical Trials Partnerships (EDCTP)
- Jan Larsson, President and CEO Business Sweden
- Irene Svenonius, Regional Stockholm Chair for Finance
- Anders Nordström, Ambassador for Global Health, Swedish Ministry of Foreign Affairs
- Anna Mia Ekström, Professor Karolinska Institutet, Senior clinical consultant Karolinska University Hospital
- Janne Lehtiö, Professor Karolinska Institutet and Scientific director SciLifeLab
- Anna Martling, Professor Karolinska Institutet, Chief physician Karolinska University Hospital
- Stephan Mielke, Professor Karolinska Institutet, Director of Centre for Allogenic Stem Cell Transplantation (CAST) at Karolinska University Hospital